RRM2B (p53R2) review notes

UniProtKB: Q7LG56 (RIR2B_HUMAN). Gene: RRM2B / P53R2. 351 aa. EC 1.17.4.1.

Core biology (grounded in UniProt + cached PMIDs)

RRM2B encodes the p53-inducible small subunit of ribonucleotide reductase (p53R2).
It is a paralog of the cell-cycle-regulated small subunit RRM2, but unlike RRM2 it is
induced by p53/TP53 in response to DNA damage and is present in resting/quiescent cells
[PMID:10716435, PMID:11517226]. Together with the large catalytic subunit RRM1 it forms an
active ribonucleotide reductase (RNR) that reduces ribonucleoside diphosphates (NDPs) to
2'-deoxyribonucleoside diphosphates (dNDPs) — the rate-limiting de novo step in dNTP supply
for DNA synthesis and repair [PMID:11517226, PMID:16376858].

Subcellular location

RNR is a cytosolic process. Pontarin et al. PMID:18997010 used three independent methods
and found R1/R2/p53R2 reside in the cytosol, arguing against the earlier nuclear-translocation
model and supporting a primary function of p53R2 for mtDNA replication. The earlier reports
described translocation cytoplasm->nucleus after DNA damage [PMID:11719458, PMID:12615712];
UniProt SUBCELLULAR LOCATION: "Cytoplasm. Nucleus. Note=Translocates from cytoplasm to nucleus
in response to DNA damage." HPA IDA supports cytosol + nucleoplasm.
Treat cytosol as the core location; nucleus/nucleoplasm/cytoplasm accepted as observed locations.
Mitochondrion IEA (GO_REF:0000108, inferred from GO:0006264) is not a documented physical
localization of the protein — RNR is cytosolic and supplies dNTPs that are imported into
mitochondria; mark over-annotated.

Disease / physiology

Annotation review reasoning

core_functions (author-supplied, strictly validated)

QA re-review 2026-07-23 (conservative, no changes)

Independent QA pass over the completed 45-annotation review. Outcome: no edits made —
no problems met the bar for a confident conservative fix.

Checks performed:
- uv run ai-gene-review validate -> ✓ Valid, no warnings.
- protein binding (GO:0005515) x3 IPI and identical protein binding (GO:0042802) x3 IPI
are all MARK_AS_OVER_ANNOTATED (none ACCEPTed), each retained-not-removed per curation
policy with the functional context (TP53, ATM/MDM2, ORC4/RNF41, homodimer) noted in the
reason. Compliant.
- Core function correctly captured and not over-generalized: two core_functions entries both
keyed on MF GO:0004748 (ribonucleoside-diphosphate reductase activity) — (1) de novo dNTP
supply via GO:0009263, (2) dNTP supply for mtDNA replication via GO:0006264 — both located to
cytosol (GO:0005829). MF is in the MF branch, both process ids in BP, location in CC: no
wrong-branch author-supplied ids.
- All PMIDs cited in supporting_text are cached but abstract-only (full_text_available: false);
validation confirms every supporting_text is a verbatim substring of the cached abstract.
- GOA/review completeness: GOA has 46 annotation rows, review has 45. The single delta is a
legitimate WITH/FROM duplicate — GO:0005515 IPI PMID:19015526 has two rows differing only in
partner (MDM2 UniProtKB:Q00987, ATM UniProtKB:Q13315), correctly collapsed to one review
annotation whose summary already names both partners. No annotation is missing.
- Description is clean project-independent biology (no this review/curation/PN framing).

Considered but deliberately left alone (not confident improvements):
- Several non-core observed locations (nucleus, nucleoplasm, cytoplasm) use ACCEPT with reasons
that describe them as "non-core observed location". KEEP_AS_NON_CORE would be marginally more
literal, but ACCEPT-with-note is a consistent, acceptable convention here; not changed.
- Cell-cycle IDA terms (GO:0010971 positive reg G2/M; GO:0070318 positive reg G0->G1) are
MARK_AS_OVER_ANNOTATED with sound arguments (cited papers show G2/M arrest / in-vitro resting
cell dNTP supply, not the annotated positive regulation). A stronger REMOVE is disallowed for
experimental annotations whose full text we have not read; over-annotated is the correct
conservative call. Left as-is.